Enveric Biosciences, Inc.ENVB

Enveric Biosciences, Inc. Earnings Per Share Disclosure

10-KFiled Mar 25, 20202 min read
NOTE 10.
EARNINGS / (LOSS) PER SHARE:
 
Basic income (loss) per share is computed based upon the weighted average number of common shares outstanding for the period. When applicable, diluted income (loss) per share is calculated using two approaches. The first approach, the treasury stock method, reflects the potential dilution that could occur if outstanding stock options, warrants, restricted stock units and outstanding shares to be awarded to satisfy contingent consideration for the business combinations described in Note 4 (collectively, the “Equity Awards”) were exercised and issued. The second approach, the if converted method, reflects the potential dilution of the Equity Awards, the 8% Convertible Unsecured Promissory Notes (the “2017 Notes”) described in Note 11 being exchanged for common stock. Under this method, interest expense, net of tax, if any, associated with the 2017 Notes, up through redemption, is added back to net income attributable to common stockholders and the shares outstanding are increased by the underlying 2017 Notes are considered to be issued.

For the twelve months ended December 31, 2019 and 2018, no shares related to the issuance of common stock upon exercise of the Equity Awards or the exchange of the 2017 Notes for common stock were considered in the calculation of diluted loss per share, as the effect would be anti-dilutive due to net losses attributable to common stockholders for both periods.

A reconciliation of net loss attributable to common stockholders and weighted average shares used in computing basic and diluted net loss per share is as follows:
 
  
For the Twelve Months Ended
 
  
December 31,
2019
  
December 31,
2018
 
Numerator for basic and diluted income (loss) per share:
      
Net income (loss) attributable to common stockholders
 
$
(6,029,978
)
  
(19,480,701
)
Numerator for diluted income (loss) per share:
        
Net income (loss) attributable to common stockholders - as reported
 
$
(6,029,978
)
  
(19,480,701
)
Interest expense on 2017 Notes, net of taxes
  
-
   
-
 
Net income (loss) attributable to common stockholders - after assumed conversions of dilutive shares
 
$
(6,029,978
)
  
(19,480,701
)
Denominator for weighted average common shares outstanding:
        
Basic shares
  
2,128,806
   
951,601
 
Dilutive effect of Equity Awards
  
-
     
Dilutive effect of 2017 Notes
  
-
   
-
 
Diluted shares
  
2,128,806
   
951,601
 
 
        
Income (loss) per share – basic:
 
$
(2.83
)
  
(20.47
)
Income (loss) per share – diluted:
 
$
(2.83
)
  
(20.47
)
 

About Earnings Per Share Disclosures

The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.

Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.

Other Available Disclosures

Income TaxesRevenueFair ValuePP&EDebtCommitmentsStock CompensationNew Standards